Moreover, in hepatocellular carcinoma (HCC), genetic dysregulation of MAPK7 expression through amplification of 17p11 is detectable in around 50% of primary HCC tumours (Zen et al., 2009 ▸). This evidence concerns the gene MAPK7 and neoplasm.